Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Terminated 1

Sponsor Class

NETWORK 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 1

Conditions

Hematologic Neoplasms 1

Interventions

Specimen Handling 16Magnetic Resonance Spectroscopy 13Vincristine 8Dexamethasone 8Radiation 7Cyclophosphamide 7Radiotherapy 6Leucovorin 6Lenalidomide 6Cisplatin 6daratumumab 5Radiotherapy, Conformal 5Radiosurgery 5Gemcitabine 5Doxorubicin 5Calcium Dobesilate 5dexamethasone acetate 4dexamethasone 21-phosphate 4auricularum 4X-Rays 4Standard of Care 4Radiotherapy, Intensity-Modulated 4Practice Guidelines as Topic 4Paclitaxel 4Etoposide 4Cytarabine 4Bortezomib 4Biopsy 4pegaspargase 3durvalumab 3

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
NETWORK × Methylprednisolone Acetate × 30 days × Clear all
NCT04438382 2026-06-02

Infliximab and Intravenous Immunoglobulin Therapy in Treating Patients With Steroid-Refractory Pneumonitis

Eastern Cooperative Oncology Group

Phase 2 Terminated
1 enrolled 1 chart
Other hematologic neoplasm

Hematologic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡